Overview

Bevacizumab Versus Combined Bevacizumab and Triamcinolone for Refractory Diabetic Macular Edema; a Randomized Clinical Trial

Status:
Unknown status

Trial end date:
2006-09-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to compare the efficacy and safety of intravitreal injection of bevacizumab alone versus bevacizumab combined with triamcinolone for treatment of refractory diabetic macular edema.

Phase:

Phase 3

Details

Lead Sponsor:

Shahid Beheshti University of Medical Sciences

Treatments:

Bevacizumab
Triamcinolone
Triamcinolone Acetonide
Triamcinolone diacetate
Triamcinolone hexacetonide